KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies-Reference-Cited by-同舟云学术

KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies

Published:2014-02 Issue:2 Volume:83 Page:163-167
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Maus M.K.H.,Grimminger P.P.,Mack P.C.,Astrow S.H.,Stephens C.,Zeger G.,Hsiang J.,Brabender J.,Friedrich M.,Alakus H.,Hölscher A.H.,Lara P.,Danenberg K.D.,Lenz H.J.,Gandara D.R.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Roles of EGFR and KRAS mutations in the treatment of patients with non-small-cell lung cancer;Langer;P T,2011

3. KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab;Lievre;J Clin Oncol,2008

4. Genetic alterations during colorectal-tumor development;Vogelstein;N Engl J Med,1988

5. Prognostic and predictive roles of KRAS mutation in colorectal cancer;Arrington;Int J Mol Sci,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations;World Journal of Oncology;2024-08

2. Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy;British Journal of Clinical Pharmacology;2024-07-30

3. High Probability of Lynch Syndrome among colorectal cancer patients in Indonesia is associated with higher occurrence of KRAS and PIK3CA mutations;2024-03-04

4. Mutational Signatures in Cancer;The Journal of Molecular Diagnostics;2023-11

5. Nitrogen‐Doped Graphene Quantum Dots as Electrochemiluminescence‐Emitting Species for Sensitive Detection of KRAS G12C Mutation via PET‐RAFT**;Chemistry – A European Journal;2023-10-11